今天开始接触FEMOIRE，好期待它的功效嗯😊

Best product ever !!!!!!!!!😍❤️

Fast delivery and received with good condition

Welcome to WellFam Club!

✨ These Community Guidelines serve as our compass, outlining the standards of conduct that help maintain the integrity and spirit of our community. ✨

We invite you to familiarize yourself with these guidelines and join us in upholding them as we embark on this fam-tastic journey together. 🎊💝

I'm getting move on for my husband. He's having issues with his knees n need to go for surgery.

Get ready to glow with matcha! This green powerhouse isn't just for tea—it's your beauty secret weapon. Here are the reasons why matcha is your new beauty secret weapon:

Hey ZENSO Buddies! ✨
Reaching your wellness goals feels fantastic, right? 🌟 Spread that feeling and help your friends and family achieve their goals too with our ZENSO Referral Program! 🎁✨

Win a ZENSO set worth RM1980 (SGD 735) and gift your friends an extra product with their purchase! Sounds pretty ZENSOtastic, right?

📢 Here’s how it works:

1. Register for the referral program.
2. Refer your friends to ZENSO.
3. Watch the rewards roll in!

Don’t miss this opportunity to earn and share the wellness journey with ZENSO products. Let’s make referring fun and rewarding! 🌟

Grab this chance now and start referring! Swipe through the photos for detailed steps and eligibility criteria 💚 💜

Iso

Where can I purchase TIGROX online?

Did You Know?🤔 Nearly 40% of Malaysian adults have non-alcoholic fatty liver disease (NAFLD), the most common liver issue in the country.

Our latest newsletter dives deep into understanding liver health! You'll explore a range of common liver conditions, the ways to prevent viral hepatitis and fatty liver, and our featured products - LIVETAL & HOMEGA to support your liver health. Also, don't miss out on our Digital Detox Challenge to give your mind and body a break!🧡✨

Click the link below to access the full newsletter and learn more about keeping your liver healthy!🥰

👉 https://cdn.wellous.com/membership/article/newsletter/2024/2024-q2-en.pdf